Search Results - "Conley AP"

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Authors: Patel BA Smith JT Wangsiricharoen S et al.

Source: Frontiers in oncology [Front Oncol] 2026 Feb 12; Vol. 16, pp. 1645629. Date of Electronic Publication: 2026 Feb 12 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

A pooled analysis of phase 2 clinical trials in advanced chordoma.

Authors: Cote GM Elliott CF Lipplaa A et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 10; Vol. 244, pp. 116875. Date of Electronic Publication: 2026 Jun 10.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Drug Screening of Sarcoma Cells: Finding Shared Sensitivities.

Authors: Beird HC Ho C Cardenas-Zuniga R et al.

Source: Cancer research communications [Cancer Res Commun] 2026 Jun 01; Vol. 6 (6), pp. 1425-1434.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Oncolytic adenoviral infection of chordoma achieves treatment efficacy associated with immunologic response and tumor microenvironmental alteration.

Authors: Wu X Ledbetter D Tsai JW et al.

Source: Neuro-oncology [Neuro Oncol] 2026 Jun 01; Vol. 28 (6), pp. 1458-1473.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Authors: Chen AP Rosenberger CL Moore N et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun; Vol. 44 (16), pp. 1490-1497. Date of Electronic Publication: 2026 Apr 18.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.

Authors: Cote GM Conley AP Attia S et al.

Source: Cancer [Cancer] 2024 Nov 15; Vol. 130 (22), pp. 3845-3854. Date of Electronic Publication: 2024 Jul 10.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.

Authors: Awad A Pal K Yevich S et al.

Source: Cancer [Cancer] 2024 Aug 01; Vol. 130 (15), pp. 2703-2712. Date of Electronic Publication: 2024 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.

Authors: Banu MA Raza SM Amini M et al.

Source: Neurosurgical focus [Neurosurg Focus] 2024 May; Vol. 56 (5), pp. E15.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Association of Neurological Surgeons Country of Publication: United States NLM ID: 100896471 Publication Model: Print Cited Medium: Internet ISSN: 1092-0684 (Electronic) Linking ISSN: 10920684 NLM ISO Abbreviation: Neurosurg Focus Subsets: MEDLINE

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Authors: Nelson BE Janku F Fu S et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Sep 15; Vol. 31 (18), pp. 3864-3875.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

Authors: Piha-Paul SA Xu B Dumbrava EE et al.

Source: The oncologist [Oncologist] 2024 Apr 04; Vol. 29 (4), pp. e514-e525.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

Authors: Traweek RS Zoghbi M Lazcano R et al.

Source: ESMO open [ESMO Open] 2025 Jul; Vol. 10 (7), pp. 105493. Date of Electronic Publication: 2025 Jun 24.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.

Authors: Tap WD Cote GM Burris H et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jun 03; Vol. 31 (11), pp. 2108-2114.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery.

Authors: Sherry AD Maroongroge S De B et al.

Source: Journal of neuro-oncology [J Neurooncol] 2023 Sep; Vol. 164 (2), pp. 377-386. Date of Electronic Publication: 2023 Sep 04.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.

Authors: Nelson BE Saleem S Damodaran S et al.

Source: Cancer [Cancer] 2023 Jul 15; Vol. 129 (14), pp. 2201-2213. Date of Electronic Publication: 2023 Apr 04.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.

Authors: Ginn MP Denu RA Ingram DR et al.

Source: Cancers [Cancers (Basel)] 2025 Apr 25; Vol. 17 (9). Date of Electronic Publication: 2025 Apr 25.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?

Authors: Patel RR Delclos GL DeSantis SM et al.

Source: American journal of clinical oncology [Am J Clin Oncol] 2025 Jan 01; Vol. 48 (1), pp. 21-27. Date of Electronic Publication: 2024 Sep 03.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE

The immune landscape of undifferentiated pleomorphic sarcoma.

Authors: Lazcano R Barreto CM Salazar R et al.

Source: Frontiers in oncology [Front Oncol] 2022 Oct 12; Vol. 12, pp. 1008484. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels.

Authors: Rubino F Alvarez-Breckenridge C Akdemir K et al.

Source: Frontiers in oncology [Front Oncol] 2022 Sep 29; Vol. 12, pp. 997506. Date of Electronic Publication: 2022 Sep 29 (Print Publication: 2022).

Publication Type: Systematic Review; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.

Authors: Ravi V Subramaniam A Zheng J et al.

Source: Cancer [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3383-3391. Date of Electronic Publication: 2022 Jul 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.

Authors: D'Angelo SP Richards AL Conley AP et al.

Source: Nature communications [Nat Commun] 2022 Jun 16; Vol. 13 (1), pp. 3477. Date of Electronic Publication: 2022 Jun 16.

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE